JP4764380B2 - Fermented milk - Google Patents
Fermented milk Download PDFInfo
- Publication number
- JP4764380B2 JP4764380B2 JP2007139980A JP2007139980A JP4764380B2 JP 4764380 B2 JP4764380 B2 JP 4764380B2 JP 2007139980 A JP2007139980 A JP 2007139980A JP 2007139980 A JP2007139980 A JP 2007139980A JP 4764380 B2 JP4764380 B2 JP 4764380B2
- Authority
- JP
- Japan
- Prior art keywords
- hyaluronic acid
- molecular weight
- salt
- less
- fermented milk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 235000015140 cultured milk Nutrition 0.000 title claims description 40
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 99
- 229920002674 hyaluronan Polymers 0.000 claims description 96
- 229960003160 hyaluronic acid Drugs 0.000 claims description 96
- 150000003839 salts Chemical class 0.000 claims description 62
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 43
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 38
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 22
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 20
- 239000002609 medium Substances 0.000 description 17
- 235000013336 milk Nutrition 0.000 description 17
- 239000008267 milk Substances 0.000 description 17
- 210000004080 milk Anatomy 0.000 description 17
- 239000002994 raw material Substances 0.000 description 17
- 239000007864 aqueous solution Substances 0.000 description 14
- 230000014759 maintenance of location Effects 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- 238000009826 distribution Methods 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 230000002378 acidificating effect Effects 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 235000013618 yogurt Nutrition 0.000 description 8
- 235000013305 food Nutrition 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 238000001556 precipitation Methods 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000004811 liquid chromatography Methods 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 6
- 229920002385 Sodium hyaluronate Polymers 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 238000011088 calibration curve Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 229940010747 sodium hyaluronate Drugs 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 235000013365 dairy product Nutrition 0.000 description 4
- 238000010908 decantation Methods 0.000 description 4
- 238000002523 gelfiltration Methods 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 3
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 150000002016 disaccharides Chemical class 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000013861 fat-free Nutrition 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- -1 hyaluronic acid salt Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229950006780 n-acetylglucosamine Drugs 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 2
- 239000000538 analytical sample Substances 0.000 description 2
- 239000002612 dispersion medium Substances 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 241001602876 Nata Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 150000004044 tetrasaccharides Chemical class 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000008924 yoghurt drink Nutrition 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Images
Landscapes
- Dairy Products (AREA)
Description
本発明は、ヒアルロン酸および/またはその塩を配合しているにもかかわらず、乳成分の分離や沈殿がなく、外観の良好な発酵乳に関する。 The present invention relates to a fermented milk having a good appearance without separation or precipitation of milk components even though hyaluronic acid and / or a salt thereof is blended.
ヒアルロン酸は生体、特に皮下組織に存在するムコ多糖類であり、その高い保湿機能によりヒアルロン酸またはその塩として、化粧料の原料に広く利用されてきた。また、ヒアルロン酸またはその塩を経口摂取することにより、生体本来の持つヒアルロン酸含量の低下を補い、肌の保湿、弾力性、および柔軟性を改善する効果が認められている。 Hyaluronic acid is a mucopolysaccharide present in living organisms, particularly subcutaneous tissues, and has been widely used as a raw material for cosmetics as hyaluronic acid or a salt thereof due to its high moisturizing function. In addition, by taking orally hyaluronic acid or a salt thereof, an effect of supplementing a decrease in hyaluronic acid content inherent in the living body and improving skin moisture retention, elasticity, and flexibility has been recognized.
近年では、機能性食品への関心が向上していることから、ヒアルロン酸およびその塩を配合した食品が数多く開発されている。その中でも、発酵乳にヒアルロン酸を配合することによって、健康や美容に対する機能の相乗効果が期待できる。 In recent years, since interest in functional foods has been improved, many foods containing hyaluronic acid and its salts have been developed. Among them, synergistic effects on health and beauty can be expected by adding hyaluronic acid to fermented milk.
このため、ヒアルロン酸およびその塩を配合した発酵乳についての開発がなされており、例えば、特開2006−522591号公報(特許文献1)には、酪農製品にヒアルロン酸を添加することにより、酪農製品のきめ性質、特に粘度に影響を及ぼし、ゲル剛性を高めることができると記載されている。また、特開平10−56983号公報(特許文献2)には、ゲル化食品にヒアルロン酸を添加する方法が記載されており、ゲル化食品としてヨーグルトの例が挙げられている。そこで発明者は、特許文献1の実施例で使用しているヒアルロン酸(商品名「ヒアルロンサンHA−F」、キユーピー(株)製、平均分子量80万)を牛乳に添加しヨーグルトを製したところ、牛乳が分離して沈殿が発生し、外観上満足できるものとは言い難かった。 For this reason, development about fermented milk which mix | blended hyaluronic acid and its salt is made | formed, for example, by adding hyaluronic acid to a dairy product in Unexamined-Japanese-Patent No. 2006-522591 (patent document 1), It is described that it can affect the texture properties of the product, in particular the viscosity, and increase the gel rigidity. Japanese Patent Laid-Open No. 10-56983 (Patent Document 2) describes a method of adding hyaluronic acid to a gelled food, and an example of yogurt is given as the gelled food. Therefore, the inventor added hyaluronic acid (trade name “Hyaluron San HA-F”, manufactured by QP Corporation, average molecular weight of 800,000) used in Examples of Patent Document 1 to milk to produce yogurt. Milk was separated and precipitation occurred, and it was difficult to say that the appearance was satisfactory.
そこで、本発明の目的は、ヒアルロン酸および/またはその塩を配合しているにもかかわらず、乳成分の分離や沈殿がなく、外観の良好な発酵乳を提供するものである。 Accordingly, an object of the present invention is to provide fermented milk having a good appearance without separation or precipitation of milk components despite the blending of hyaluronic acid and / or a salt thereof.
本発明者は、上記目的を達成すべく、ヒアルロン酸について鋭意研究を重ねた結果、平均分子量が特定以下のヒアルロン酸および/またはその塩を配合するならば、意外にも、乳成分の分離や沈殿のない、外観の良好な発酵乳が得られることを見出し、本発明を完成するに至った。 As a result of intensive studies on hyaluronic acid to achieve the above object, the present inventor unexpectedly separated milk components if hyaluronic acid and / or a salt thereof having an average molecular weight below a specific value was blended. The inventors found that fermented milk having a good appearance and no precipitation can be obtained, and the present invention has been completed.
すなわち、本発明は、
(1)平均分子量30万以下のヒアルロン酸および/またはその塩を含有することを特徴とする発酵乳、
(2)平均分子量5万以下のヒアルロン酸および/またはその塩を含有することを特徴とする(1)の発酵乳、
(3)平均分子量2万以下のヒアルロン酸および/またはその塩を含有することを特徴とする(1)又は(2)のいずれかの発酵乳、
(4)ヒアルロン酸および/またはその塩の分子量分布が、分子量1万以下の成分の割合が40%以上、かつ分子量5万以上の成分の割合が5%以下である(2)又は(3)のいずれかの発酵乳、
(5)ヒアルロン酸および/またはその塩の配合量が、0.001〜10%である(1)乃至(4)のいずれかの発酵乳、
である。
That is, the present invention
(1) Fermented milk comprising hyaluronic acid having an average molecular weight of 300,000 or less and / or a salt thereof,
(2) fermented milk according to (1), comprising hyaluronic acid and / or a salt thereof having an average molecular weight of 50,000 or less,
(3) Fermented milk according to any one of (1) and (2), comprising hyaluronic acid having an average molecular weight of 20,000 or less and / or a salt thereof,
(4) The molecular weight distribution of hyaluronic acid and / or a salt thereof is such that the proportion of components having a molecular weight of 10,000 or less is 40% or more and the proportion of components having a molecular weight of 50,000 or more is 5% or less (2) or (3) Any fermented milk,
(5) The fermented milk according to any one of (1) to (4), wherein the blending amount of hyaluronic acid and / or a salt thereof is 0.001 to 10%,
It is.
本発明によれば、ヒアルロン酸および/またはその塩が配合されているにもかかわらず、乳成分の分離や沈殿のない発酵乳を提供することができる。したがって、食品市場でのヒアルロン酸および/またはその塩の更なる利用拡大が期待できる。 ADVANTAGE OF THE INVENTION According to this invention, although hyaluronic acid and / or its salt are mix | blended, fermented milk without isolation | separation and precipitation of a milk component can be provided. Therefore, further expansion of utilization of hyaluronic acid and / or a salt thereof in the food market can be expected.
以下、本発明を詳細に説明する。なお、本発明において「%」は「質量%」を意味する。 Hereinafter, the present invention will be described in detail. In the present invention, “%” means “mass%”.
本発明の発酵乳は、乳、またはこれと同等以上の無脂乳固形分を含む乳等を乳酸菌又は酵母で発酵させ、糊状または液状にしたもの、またはそれを凍結したものであり、プレーンタイプのヨーグルト、ハードタイプのフルーツヨーグルト、飲むヨーグルト、フローズンヨーグルト等が挙げられる。 The fermented milk of the present invention is obtained by fermenting milk or milk containing non-fat milk solid content equal to or higher than this with lactic acid bacteria or yeast to make paste or liquid, or by freezing it. Type yogurt, hard type fruit yogurt, drinking yogurt, frozen yogurt and the like.
本発明は、上記発酵乳において、平均分子量30万以下のヒアルロン酸および/またはその塩を含有することを特徴とする。ここで、「ヒアルロン酸」とは、グルクロン酸とN−アセチルグルコサミンとの二糖からなる繰り返し構成単位を1以上有する多糖類をいう。また、「ヒアルロン酸の塩」としては、特に限定されないが、食品又は薬学上許容しうる塩であることが好ましく、例えば、ナトリウム塩、カリウム塩、カルシウム塩、亜鉛塩、マグネシウム塩、アンモニウム塩等が挙げられる。 The present invention is characterized in that the fermented milk contains hyaluronic acid having an average molecular weight of 300,000 or less and / or a salt thereof. Here, “hyaluronic acid” refers to a polysaccharide having one or more repeating structural units composed of disaccharides of glucuronic acid and N-acetylglucosamine. The “hyaluronic acid salt” is not particularly limited, but is preferably a food or pharmaceutically acceptable salt, for example, sodium salt, potassium salt, calcium salt, zinc salt, magnesium salt, ammonium salt, etc. Is mentioned.
また、本発明に使用するヒアルロン酸またはその塩は、平均分子量が30万以下であり、好ましくは5万以下であり、より好ましくは2万以下である。ヒアルロン酸またはその塩の平均分子量が前記値より大きいと、当該ヒアルロン酸および/またはその塩を乳製品に配合した場合、乳成分の分離や沈殿が発生し、本発明の目的とする外観の良好な発酵乳とならないからである。なお、本発明では、平均分子量の下限値を限定していないが、精製度の高いヒアルロン酸またはその塩の工業的生産性を考慮し、平均分子量5千以上が好ましい。 The hyaluronic acid or a salt thereof used in the present invention has an average molecular weight of 300,000 or less, preferably 50,000 or less, more preferably 20,000 or less. When the average molecular weight of hyaluronic acid or a salt thereof is larger than the above value, when the hyaluronic acid and / or a salt thereof is blended into a dairy product, separation or precipitation of milk components occurs, and the desired appearance of the present invention is good. This is because it does not become a fermented milk. In the present invention, the lower limit of the average molecular weight is not limited, but an average molecular weight of 5,000 or more is preferable in consideration of industrial productivity of hyaluronic acid or a salt thereof having a high degree of purification.
本発明で規定される平均分子量の測定方法について説明する。 The measurement method of the average molecular weight prescribed | regulated by this invention is demonstrated.
本発明で規定される平均分子量は、ヒアルロン酸および/またはその塩の極限粘度から算出された分子量である。ヒアルロン酸および/またはその塩の極限粘度を求めるには、まず、複数のヒアルロン酸および/またはその塩の水溶液を調製し、ウベローデ粘度計(柴田科学器械工業株式会社)におけるヒアルロン酸および/またはその塩の水溶液の流下秒数および溶媒の流下秒数から、下記式1および式2に基づいて比粘度および還元粘度を算出する。この際、流下秒数が200〜1000秒になるような係数のウベローデ粘度計を用いる。また、ヒアルロン酸および/またはその塩の水溶液の濃度は、該測定器に適する濃度を選択する。また、測定は30℃の恒温水槽中で行い、温度変化のないようにする。
(式1)
(式2)
The average molecular weight defined in the present invention is a molecular weight calculated from the intrinsic viscosity of hyaluronic acid and / or a salt thereof. In order to determine the intrinsic viscosity of hyaluronic acid and / or a salt thereof, first, an aqueous solution of a plurality of hyaluronic acid and / or a salt thereof is prepared, and hyaluronic acid and / or the solution thereof in an Ubbelohde viscometer (Shibata Scientific Instruments Co., Ltd.) is prepared. The specific viscosity and the reduced viscosity are calculated based on the following formulas 1 and 2 from the flowing seconds of the aqueous salt solution and the flowing seconds of the solvent. At this time, an Ubbelohde viscometer having a coefficient such that the number of seconds of flow is 200 to 1000 seconds is used. The concentration of the aqueous solution of hyaluronic acid and / or a salt thereof is selected to be suitable for the measuring instrument. The measurement is performed in a constant temperature water bath at 30 ° C. so that there is no temperature change.
(Formula 1)
(Formula 2)
次いで、各ヒアルロン酸および/またはその塩の水溶液について、得られた還元粘度を縦軸に、乾燥物換算のヒアルロン酸および/またはその塩濃度を横軸にプロットして検量線を作成し、前記ヒアルロン酸および/またはその塩濃度を0に外挿することにより、ヒアルロン酸および/またはその塩の極限粘度を得る。下記式3に基づいて、ヒアルロン酸および/またはその塩の極限粘度から平均分子量Mを求めることができる。
(式3)
極限粘度(dL/g)=K’Mα
(上記式3において、K’=0.036、α=0.78である。)
Next, for each aqueous solution of hyaluronic acid and / or salt thereof, a calibration curve was prepared by plotting the obtained reduced viscosity on the vertical axis and the hyaluronic acid and / or salt concentration in terms of dry matter on the horizontal axis, By extrapolating hyaluronic acid and / or its salt concentration to zero, the intrinsic viscosity of hyaluronic acid and / or its salt is obtained. Based on the following formula 3, the average molecular weight M can be determined from the intrinsic viscosity of hyaluronic acid and / or a salt thereof.
(Formula 3)
Intrinsic viscosity (dL / g) = K′M α
(In the above formula 3, K ′ = 0.036 and α = 0.78.)
本発明に使用するヒアルロン酸および/またはその塩は、平均分子量30万以下、好ましくは5万以下、より好ましくは2万以下であることに加え、その分子量分布において、分子量1万以下の成分の割合が40%以上で、かつ、分子量5万以上の成分の割合が5%以下であることが好ましい。このような分子量分布のヒアルロン酸および/またはその塩を使用することにより、特に乳製品に高濃度に配合した場合にも、乳成分の分離、沈殿が起こりにくく、効果的である。 The hyaluronic acid and / or salt thereof used in the present invention has an average molecular weight of 300,000 or less, preferably 50,000 or less, and more preferably 20,000 or less. It is preferable that the ratio is 40% or more and the ratio of components having a molecular weight of 50,000 or more is 5% or less. Use of hyaluronic acid and / or a salt thereof having such a molecular weight distribution is effective in that separation and precipitation of milk components hardly occur even when blended in dairy products at a high concentration.
本発明で規定される分子量分布は、ゲル濾過カラムを用いてヒアルロン酸および/またはその塩を液体クロマトグラフィー分析することにより得られる。ヒアルロン酸および/またはその塩は、反復構造単位(N−アセチル−D−グルコサミンおよびD−グルクロン酸)の数によって異なる分子量を有する複数の成分の混合物である。したがって、ゲル濾過カラムを用いてヒアルロン酸および/またはその塩の水溶液について液体クロマトグラフィー分析を行うことにより、ヒアルロン酸および/またはその塩を構成する成分を分子サイズにより分離することができる。 The molecular weight distribution defined in the present invention can be obtained by liquid chromatography analysis of hyaluronic acid and / or a salt thereof using a gel filtration column. Hyaluronic acid and / or a salt thereof is a mixture of a plurality of components having different molecular weights depending on the number of repeating structural units (N-acetyl-D-glucosamine and D-glucuronic acid). Accordingly, by performing liquid chromatography analysis on an aqueous solution of hyaluronic acid and / or a salt thereof using a gel filtration column, the components constituting hyaluronic acid and / or the salt thereof can be separated by molecular size.
本発明におけるヒアルロン酸および/またはその塩の分子量分布は、HPLC分析装置(商品名「アライアンスPDAシステム」、日本ウォーターズ株式会社製)にゲル濾過カラム(商品名「Diol−120」、株式会社ワイエムシイ製)を接続して、ヒアルロン酸および/またはその塩の0.1%(w/v)水溶液を分析サンプルとして、この分析サンプルを液体クロマトグラフィー分析することにより測定することができる。 The molecular weight distribution of hyaluronic acid and / or a salt thereof in the present invention is determined by HPLC analysis device (trade name “Alliance PDA System”, manufactured by Nippon Waters Co., Ltd.) and gel filtration column (trade name “Diol-120”, manufactured by YMC Co., Ltd.). ) And a 0.1% (w / v) aqueous solution of hyaluronic acid and / or its salt as an analytical sample, and this analytical sample can be measured by liquid chromatography analysis.
液体クロマトグラフィー分析の条件は以下の通りとする。
カラム温度:40℃
流速:1mL/分
ヒアルロン酸および/またはその塩の0.1%(w/v)水溶液の注入量:20μL
移動相:0.003mol/L リン酸バッファー(0.15mol/L NaCl含有、pH7.0)
紫外線検出器:λ=210nmで測定
本発明に係るゲル濾過カラムを用いた液体クロマトグラフィーでは、保持時間が長いものほど低分子である。保持時間の長い順に、N−アセチルグルコサミン、D−グルクロン酸、ヒアルロン酸(二糖:繰り返し構造単位1つ)、ヒアルロン酸(四糖:繰り返し構造単位2つ)、ヒアルロン酸(六糖:繰り返し構造単位3つ)、ヒアルロン酸(八糖:繰り返し構造単位4つ)・・・のピークが得られる。各ピークにおける保持時間および分子量を算出し、この保持時間対分子量の検量線を求める(式4)。
The conditions for liquid chromatography analysis are as follows.
Column temperature: 40 ° C
Flow rate: 1 mL / min Injection volume of 0.1% (w / v) aqueous solution of hyaluronic acid and / or its salt: 20 μL
Mobile phase: 0.003 mol / L phosphate buffer (containing 0.15 mol / L NaCl, pH 7.0)
Ultraviolet detector: measured at λ = 210 nm In the liquid chromatography using the gel filtration column according to the present invention, the longer the retention time, the lower the molecular weight. In order of decreasing retention time, N-acetylglucosamine, D-glucuronic acid, hyaluronic acid (disaccharide: one repeating structural unit), hyaluronic acid (tetrasaccharide: two repeating structural units), hyaluronic acid (hexasaccharide: repeating structure) Peaks of 3 units), hyaluronic acid (octasaccharide: 4 repeating structural units)... Are obtained. The retention time and molecular weight at each peak are calculated, and a calibration curve of this retention time versus molecular weight is obtained (Formula 4).
なお、後述の式4において、xは保持時間を示し、yは分子量を示す。次いで、式4に示される検量線から、所定の分子量(1万または5万)に対応する保持時間を算出し、これらの保持時間によりピークを分割することにより、所定の分子量範囲にある成分の割合を求める。また、各ピークが示す分子量は、分子量が既知のヒアルロン酸および/またはその塩の最小構成単位(二糖)について同様の方法で液体クロマトグラフィー分析して得られたクロマトグラム中のピークと照会することにより同定される。 In formula 4 described later, x represents a retention time, and y represents a molecular weight. Next, from the calibration curve shown in Equation 4, a retention time corresponding to a predetermined molecular weight (10,000 or 50,000) is calculated, and by dividing the peak by these retention times, the components in the predetermined molecular weight range are calculated. Find the percentage. The molecular weight indicated by each peak is referred to the peak in the chromatogram obtained by liquid chromatography analysis of the smallest structural unit (disaccharide) of hyaluronic acid and / or its salt with a known molecular weight in the same manner. To be identified.
例えば、分子量1万以下の成分の割合は、式4に示される検量線から分子量1万に対応する保持時間を算出し、この保持時間以降の成分の吸収面積を全吸収面積で除すことにより求めることができる。同様に、分子量5万以上の成分の割合は、式4に示される検量線から分子量5万に対応する保持時間を算出し、この保持時間以前に成分の吸収面積を全吸収面積で除すことにより求めることができる。 For example, the ratio of components having a molecular weight of 10,000 or less is calculated by calculating a retention time corresponding to a molecular weight of 10,000 from the calibration curve shown in Equation 4, and dividing the absorption area of the component after this retention time by the total absorption area. Can be sought. Similarly, for the proportion of components having a molecular weight of 50,000 or more, the retention time corresponding to the molecular weight of 50,000 is calculated from the calibration curve shown in Equation 4, and the absorption area of the component is divided by the total absorption area before this retention time. It can ask for.
一例として、図1に示すクロマトグラムから得られた各分子量成分の繰り返し単位数および保持時間の関係を表1に示す。 As an example, Table 1 shows the relationship between the number of repeating units of each molecular weight component obtained from the chromatogram shown in FIG.
(式4)
y=−21.4x3+1296.2x2−26747.1x+189427.1
(Formula 4)
y = -21.4x < 3 > + 1296.2x < 2 > -267477.1x + 189427.1
本発明で用いる平均分子量30万以下、好ましくは5万以下、より好ましくは2万以下の低分子ヒアルロン酸および/またはその塩の代表的な製造方法を以下に述べる。なお、本発明で用いる低分子ヒアルロン酸および/またはその塩の製造方法は、これに限定するものではない。 A typical method for producing low molecular weight hyaluronic acid and / or a salt thereof having an average molecular weight of 300,000 or less, preferably 50,000 or less, more preferably 20,000 or less used in the present invention will be described below. In addition, the manufacturing method of the low molecular hyaluronic acid and / or its salt used by this invention is not limited to this.
上記低分子ヒアルロン酸および/またはその塩の原料であるヒアルロン酸および/またはその塩(以下、「原料ヒアルロン酸およびその塩」ともいう)は一般に、鶏冠、臍の緒、眼球、皮膚、軟骨等の生物組織、あるいはストレプトコッカス属の微生物等のヒアルロン酸生産微生物を培養して得られる培養液等を原料として、これらの原料から抽出(さらに必要に応じて精製)して得られるものである。例えば、鶏冠より抽出される原料ヒアルロン酸および/またはその塩の分子量は通常200万から800万である。 Hyaluronic acid and / or a salt thereof (hereinafter also referred to as “raw hyaluronic acid and a salt thereof”), which is a raw material for the low molecular hyaluronic acid and / or salt thereof, is generally a living organism such as a chicken crown, umbilical cord, eyeball, skin, cartilage, and the like. It is obtained by extracting (and purifying as necessary) these raw materials from a culture solution obtained by culturing hyaluronic acid-producing microorganisms such as tissues or microorganisms belonging to the genus Streptococcus. For example, the molecular weight of the raw material hyaluronic acid and / or its salt extracted from a chicken crown is usually 2 million to 8 million.
上記低分子ヒアルロン酸および/またはその塩は、酸性含水媒体中に原料ヒアルロン酸および/またはその塩を分散させて、酸性含水媒体を除去して得られた残留物を加熱乾燥することにより製造することができる。ここで、攪拌速度や攪拌時間を調整することにより、低分子化の度合いを調整することができる。また、上述の分散させる工程を、30〜70℃で1時間以内の加熱条件下で行うことにより、目的の分子量まで安定に低分子化することができる。より具体的には、粉末状の原料ヒアルロン酸および/またはその塩を、酸性含水媒体中に攪拌しながら添加して得られた分散媒を加熱することができる。あるいは、酸性含水媒体を予め加熱し、これに原料ヒアルロン酸および/またはその塩を添加し、温度を保持してもよい。 The low molecular weight hyaluronic acid and / or salt thereof is produced by dispersing the raw material hyaluronic acid and / or salt thereof in an acidic water-containing medium and removing the acidic water-containing medium by heating and drying. be able to. Here, the degree of low molecular weight can be adjusted by adjusting the stirring speed and stirring time. Moreover, by performing the above-mentioned dispersion | distribution process on 30-70 degreeC on the heating conditions for less than 1 hour, it can be made low molecular weight stably to the target molecular weight. More specifically, the dispersion medium obtained by adding the powdered raw material hyaluronic acid and / or salt thereof to the acidic water-containing medium while stirring can be heated. Alternatively, the acidic water-containing medium may be heated in advance, and raw material hyaluronic acid and / or a salt thereof may be added thereto to maintain the temperature.
上記製造方法において、含水媒体は、水を含む、ヒアルロン酸および/またはその塩の分散媒のことをいう。含水媒体に使用できる媒体は、ヒアルロン酸および/またはその塩の溶解性が低いことが好ましい。含水媒体に使用できる媒体は特に限定されないが、例えば液体であって、水に溶解する性質を有し、かつ、食品または医薬品の製造工程において使用できるものが好ましい。含水媒体に使用できる媒体としては、例えば、アルコール系媒体(例えば、メタノール、エタノール、n−プロパノール、2−プロパノールなど)、ケトン系媒体(例えば、アセトン、メチルエチルケトンなど)、テトラヒドロフラン、アセトニトリル等を挙げることができ、これらを単独または組み合わせて使用することができる。このうち、沸点の低さおよび価格の点で、メタノール、エタノール、およびアセトンから選ばれる少なくとも1種であることが好ましい。含水媒体における含水量は特に規定されないが、含水量が多いと、ヒアルロン酸および/またはその塩が分散状態を維持できず、含水媒体に溶解するため、収率の低下を招くおそれがある。したがって、含水媒体の全量に対する水の割合は40%容量以下が好ましく、30%容量以下がより好ましい。 In the above production method, the water-containing medium refers to a dispersion medium of hyaluronic acid and / or a salt thereof containing water. The medium that can be used as the water-containing medium preferably has low solubility of hyaluronic acid and / or a salt thereof. The medium that can be used as the water-containing medium is not particularly limited, but for example, a liquid that has a property of being dissolved in water and that can be used in the production process of food or medicine is preferable. Examples of the medium that can be used as the water-containing medium include alcohol-based media (for example, methanol, ethanol, n-propanol, 2-propanol, etc.), ketone-based media (for example, acetone, methyl ethyl ketone, etc.), tetrahydrofuran, acetonitrile, and the like. These can be used alone or in combination. Among these, it is preferable that it is at least 1 sort (s) chosen from methanol, ethanol, and acetone at the point of the low boiling point and a price. The water content in the water-containing medium is not particularly specified, but if the water content is large, the hyaluronic acid and / or salt thereof cannot be maintained in a dispersed state and is dissolved in the water-containing medium, which may lead to a decrease in yield. Therefore, the ratio of water to the total amount of the water-containing medium is preferably 40% capacity or less, more preferably 30% capacity or less.
また、上記製造方法において、含水媒体を酸性にするために使用するものとしては、例えば、塩酸や硫酸等の酸や酸性陽イオン交換樹脂が挙げられる。 Moreover, in the said manufacturing method, as what is used in order to make a water-containing medium acidic, acids, such as hydrochloric acid and a sulfuric acid, and acidic cation exchange resin are mentioned, for example.
なお、平均分子量30万以下、好ましくは5万以下、より好ましくは2万以下の低分子ヒアルロン酸からヒアルロン酸の塩へと変換する方法、ならびに前記低分子ヒアルロン酸の塩からヒアルロン酸へと変換する方法は、特に限定されるわけではない。前記低分子ヒアルロン酸からヒアルロン酸の塩へと変換する方法としては、例えば、アルカリ水溶液(例えば、水酸化ナトリウム、水酸化カリウム、水酸化カルシウム、水酸化マグネシウム、水酸化アンモニウム等の水溶液)を用いて処理する方法が挙げられる。また、前記低分子ヒアルロン酸の塩からヒアルロン酸へと変換する方法としては、例えば、酸水溶液(例えば、塩酸、硫酸、硝酸、リン酸等の水溶液)を用いて処理する方法や、酸性陽イオン交換樹脂を用いる方法が挙げられる。 A method of converting a low molecular weight hyaluronic acid having an average molecular weight of 300,000 or less, preferably 50,000 or less, more preferably 20,000 or less into a hyaluronic acid salt, and conversion from the low molecular hyaluronic acid salt to hyaluronic acid The method to do is not specifically limited. As a method for converting the low molecular weight hyaluronic acid into a hyaluronic acid salt, for example, an alkaline aqueous solution (for example, an aqueous solution of sodium hydroxide, potassium hydroxide, calcium hydroxide, magnesium hydroxide, ammonium hydroxide, etc.) is used. And processing method. Examples of the method for converting the low molecular weight hyaluronic acid salt into hyaluronic acid include, for example, a method of treating with an acid aqueous solution (for example, an aqueous solution of hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, etc.), an acidic cation, and the like. A method using an exchange resin may be mentioned.
本発明の発酵乳において、上述した製造方法等により得られた平均分子量30万以下、好ましくは5万以下、より好ましくは2万以下の低分子ヒアルロン酸および/またはその塩の配合量は、0.001〜10%程度が好ましく、0.005〜2%程度がより好ましい。ヒアルロン酸および/またはその塩の配合量が、前記範囲より多くなると、ヒアルロン酸および/またはその塩の風味が強くなり、発酵乳本来のおいしさが損なわれるため、好ましくない。一方、前記範囲より少なくなると、ヒアルロン酸および/またはその塩の美容効果が現れにくく、商品価値が低くなるため好ましくない。 In the fermented milk of the present invention, the blending amount of low molecular weight hyaluronic acid and / or a salt thereof having an average molecular weight of 300,000 or less, preferably 50,000 or less, more preferably 20,000 or less obtained by the above-described production method is 0. About 0.001 to 10% is preferable, and about 0.005 to 2% is more preferable. If the blending amount of hyaluronic acid and / or salt thereof is more than the above range, the flavor of hyaluronic acid and / or salt thereof becomes strong and the original taste of fermented milk is impaired. On the other hand, if the amount is less than the above range, the cosmetic effect of hyaluronic acid and / or a salt thereof hardly appears and the commercial value is lowered, which is not preferable.
本発明の発酵乳の製造方法は、本発明の必須の配合原料である上述した平均分子量30万以下、好ましくは5万以下、より好ましくは2万以下の低分子ヒアルロン酸またはその塩を、乳、またはこれと同等以上の無脂乳固形分を含む乳等、または発酵乳に配合する工程を含む方法であれば特に限定されるものではない。一般的な発酵乳の製造方法としては、タンク内で発酵・冷却を完了させた発酵乳を破砕して流通用個食容器に充填した前発酵タイプと、一定量のスターターを添加した発酵乳原料ミックスを流通用個食容器に充填した後、発酵室にて所定の乳酸酸度に到達するまで発酵させた後に冷却する、後発酵タイプとに大別されている。本発明は、いずれの方法でもよい。 The method for producing fermented milk of the present invention comprises the above-described low molecular weight hyaluronic acid or a salt thereof having an average molecular weight of 300,000 or less, preferably 50,000 or less, more preferably 20,000 or less, which is the essential ingredient of the present invention. Or milk containing a non-fat milk solid content equal to or higher than this, or a method including a step of blending with fermented milk, is not particularly limited. As a general method for producing fermented milk, fermented milk ingredients that have been fermented and cooled in a tank are pre-fermented and crushed and filled into individual containers for distribution, and a certain amount of starter is added. After filling the mix into a single-use container for distribution, the mixture is roughly classified into a post-fermentation type that is fermented until reaching a predetermined degree of lactic acid in the fermentation chamber and then cooled. The present invention may be any method.
本発明は、本発明の効果を損なわない範囲で、発酵乳に一般的に使用されている原料を適宜配合することができる。このような原料としては、例えば、砂糖、粉糖、グラニュー糖、果糖、水飴、はちみつ、フルクトース、パラチノース、トレハロース、ラクトース、キシロース等の糖類、寒天、ゼラチン、澱粉、カラギナン、キサンタンガム、デキストリン、ペクチン等の食感改良材、ソルビトール、マルチトール、キシリトール、エリスリトール、還元水飴、還元麦芽糖水飴等の糖アルコール類、スクラロース、ステビア、アスパルテーム等の高甘味度甘味料、クエン酸、乳酸等の酸材、ビタミンA、ビタミンB類、ビタミンC、ビタミンD等のビタミン類、コラーゲン、水溶性食物繊維等の美容原料、乳製品、乳たんぱく、色素、果汁、植物性油脂、卵黄、香料等が挙げられる。また、イチゴ、ブルーベリー、みかん、パイナップル、キウイ、メロン、桃、りんご等の果肉やジャム、ナタデココなど、分散可能な固形食品を含んでもよい。 This invention can mix | blend suitably the raw material generally used for fermented milk in the range which does not impair the effect of this invention. Examples of such raw materials include sugar, powdered sugar, granulated sugar, fructose, starch syrup, honey, fructose, palatinose, trehalose, lactose, xylose and other sugars, agar, gelatin, starch, carrageenan, xanthan gum, dextrin, pectin, etc. Texture improver, sugar alcohols such as sorbitol, maltitol, xylitol, erythritol, reduced starch syrup, reduced maltose starch syrup, high sweetness sweeteners such as sucralose, stevia, aspartame, acid materials such as citric acid, lactic acid, vitamins Examples include vitamins such as A, vitamin B, vitamin C, and vitamin D, cosmetic raw materials such as collagen and water-soluble dietary fiber, dairy products, milk protein, pigments, fruit juice, vegetable oils, egg yolk, and fragrances. In addition, dispersible solid foods such as strawberry, blueberry, mandarin orange, pineapple, kiwi, melon, peach, apple and other pulps, jams, and nata de coco can be included.
以下、本発明で用いる平均分子量30万以下、好ましくは5万以下、より好ましくは2万以下の低分子ヒアルロン酸および/またはその塩を用いた発酵乳について、実施例等に基づき具体的に説明する。なお、本発明は、これらに限定するものではない。 Hereinafter, fermented milk using low molecular weight hyaluronic acid and / or a salt thereof having an average molecular weight of 300,000 or less, preferably 50,000 or less, and more preferably 20,000 or less used in the present invention will be specifically described based on Examples and the like. To do. The present invention is not limited to these.
〔調製例1〕平均分子量9千のヒアルロン酸
本調製例では、原料として、鶏冠より抽出、精製したヒアルロン酸ナトリウム(以下「HANa」ともいう)微粉末を準備した。この原料HANaの平均分子量は約210万、純度97%であった。
[Preparation Example 1] Hyaluronic acid with an average molecular weight of 9000 In this preparation example, a sodium hyaluronate (hereinafter also referred to as “HANa”) fine powder extracted and purified from a chicken crown was prepared as a raw material. The raw material HANa had an average molecular weight of about 2.1 million and a purity of 97%.
まず、攪拌機およびジャケットを装備した300L容タンクに、0.5%硫酸含有80%含水アセトン(酸性含水媒体)110Lを満たし、攪拌しながら液温が60℃となるよう加熱した。ここで、80%含水アセトンは、アセトンを80(w/w)%含有し、水を20(w/w)%含有するものであり、0.5%硫酸含有80%アセトンは、硫酸を0.5(w/w)%含有し、80%含水アセトンを99.5(w/w)%含有するものである。60℃に達温後、攪拌しながら、準備した原料HANa微粉末6kgをタンクに投入した。硫酸含有含水アセトンの温度を60℃に維持するよう加熱を行いながら、原料HANa微粉末が分散状態となるように攪拌した。 First, a 300 L tank equipped with a stirrer and a jacket was filled with 110 L of 0.5% sulfuric acid-containing 80% water-containing acetone (acidic water-containing medium), and heated with stirring to a liquid temperature of 60 ° C. Here, 80% water-containing acetone contains 80 (w / w)% acetone and 20 (w / w)% water, and 80% acetone containing 0.5% sulfuric acid contains 0% sulfuric acid. 0.5 (w / w)% and 80% water-containing acetone is contained 99.5 (w / w)%. After reaching 60 ° C., 6 kg of the prepared raw material HANa fine powder was charged into the tank while stirring. While heating so as to maintain the temperature of the sulfuric acid-containing water-containing acetone at 60 ° C., the raw material HANa fine powder was stirred so as to be in a dispersed state.
次に、15分間攪拌してから静置した後、上澄みの硫酸含有含水アセトンをデカンテーションにより除去することにより、沈殿物を得た。得られた沈殿物に、予め60℃に加熱した0.5%硫酸含有80%含水アセトン110Lを加え、同様に60℃に加熱しながら攪拌を15分間行い、この操作を合計3回繰り返した。 Next, after stirring for 15 minutes and allowing to stand, the supernatant sulfuric acid-containing water-containing acetone was removed by decantation to obtain a precipitate. To the obtained precipitate, 110 L of 80% water-containing acetone containing 0.5% sulfuric acid previously heated to 60 ° C. was added, and similarly stirred for 15 minutes while heating to 60 ° C. This operation was repeated a total of 3 times.
次いで、硫酸含有含水アセトンを除去した後に得られた沈殿物に80%含水アセトン110Lを加え、硫酸除去の目的で攪拌を15分間行った。硫酸の残留がなくなるまでこの操作を繰り返した。 Next, 110 L of 80% water-containing acetone was added to the precipitate obtained after removing sulfuric acid-containing water-containing acetone, and stirring was performed for 15 minutes for the purpose of removing sulfuric acid. This operation was repeated until no sulfuric acid remained.
さらに、含水アセトンをデカンテーションにより除去して残留物を得た。この残留物について遠心分離処理を行うことにより含水アセトンをさらに除去した後、真空乾燥機を用いて70℃にて減圧で12時間加熱乾燥した。 Furthermore, water-containing acetone was removed by decantation to obtain a residue. The residue was further centrifuged to remove water-containing acetone, and then dried by heating at 70 ° C. under reduced pressure for 12 hours using a vacuum dryer.
以上の工程により、白色微粉末のヒアルロン酸5.3kg(収率約88%)を得た。このヒアルロン酸は、極限粘度より換算した平均分子量が9千であり、分子量分布において、分子量1万以下の成分の割合が49%以上でかつ分子量5万以上の成分の割合が0.5%であった。 Through the above steps, 5.3 kg of hyaluronic acid (yield: about 88%) was obtained as white fine powder. This hyaluronic acid has an average molecular weight of 9,000 converted from intrinsic viscosity, and in the molecular weight distribution, the proportion of components having a molecular weight of 10,000 or less is 49% or more and the proportion of components having a molecular weight of 50,000 or more is 0.5%. there were.
〔調製例2〕平均分子量3.5万のヒアルロン酸ナトリウム
本調製例では、原料として、調製例1で用いたHANa微粉末を準備した。
[Preparation Example 2] Sodium hyaluronate having an average molecular weight of 35,000 In this preparation example, the HANa fine powder used in Preparation Example 1 was prepared as a raw material.
まず、攪拌機を装備した300L容タンクに、2%塩酸含有73%含水エタノール(酸性含水媒体)110Lを満たし、攪拌しながら液温が50℃となるよう加熱した。ここで、73%含水エタノールは、エタノールを73(w/w)%含有し、水を27(w/w)%含有するものであり、2%塩酸含有73%含水エタノールは、塩酸を2(w/w)%含有し、73%含水エタノールを98(w/w)%含有するものである。50℃に達温後、攪拌しながら、準備した原料HANa微粉末6kgをタンクに投入した。塩酸含有含水エタノールの温度を50℃に維持するよう加熱を行いながら、原料HA粉末が分散状態となるように攪拌した。 First, a 300 L tank equipped with a stirrer was filled with 110 L of 73% water-containing ethanol (acidic water-containing medium) containing 2% hydrochloric acid, and heated to 50 ° C. while stirring. Here, 73% hydrous ethanol contains 73 (w / w)% ethanol and 27 (w / w)% water, and 73% hydrous ethanol containing 2% hydrochloric acid contains 2 ( w / w)%, and it contains 98% (w / w)% of 73% water-containing ethanol. After the temperature reached 50 ° C., 6 kg of the prepared raw material HANa fine powder was charged into the tank while stirring. While heating to maintain the temperature of the hydrochloric acid-containing aqueous ethanol at 50 ° C., the raw material HA powder was stirred so as to be in a dispersed state.
次に、15分間攪拌してから静置した後、上澄みの塩酸含有含水エタノールをデカンテーションにより除去することにより、沈殿物を得た。得られた沈殿物に、予め50℃に加熱した2%塩酸含有73%含水エタノール110Lを加え、同様に50℃に加熱しながら攪拌を15分間行い、この操作を合計3回繰り返した。 Next, after stirring for 15 minutes and allowing to stand, the supernatant hydrochloric acid-containing aqueous ethanol was removed by decantation to obtain a precipitate. To the obtained precipitate, 110 L of 73% water-containing ethanol containing 2% hydrochloric acid previously heated to 50 ° C. was added, and similarly stirred for 15 minutes while heating to 50 ° C. This operation was repeated a total of 3 times.
次いで、塩酸含有含水エタノールを除去した後に得られた沈殿物に73%含水エタノール110Lを加え、塩酸除去の目的で攪拌を15分間行った。塩酸の残留がなくなるまでこの操作を繰り返した。 Next, 110 L of 73% aqueous ethanol was added to the precipitate obtained after removing the hydrochloric acid-containing aqueous ethanol, and the mixture was stirred for 15 minutes for the purpose of removing hydrochloric acid. This operation was repeated until no hydrochloric acid remained.
さらに、含水エタノールをデカンテーションにより除去して残留物を得た。この残留物について遠心分離処理を行うことにより含水エタノールをさらに除去した後、再び同タンクにて水100Lに溶解させて水溶液を調製した。この水溶液を攪拌しながら20%水酸化ナトリウム溶液を該水溶液に添加して、pH6.5とした。次いで、この水溶液をスプレードライヤーにて噴霧乾燥を行った。 Furthermore, the water-containing ethanol was removed by decantation to obtain a residue. The residue was further centrifuged to remove water-containing ethanol and then dissolved again in 100 L of water in the same tank to prepare an aqueous solution. While stirring the aqueous solution, a 20% sodium hydroxide solution was added to the aqueous solution to adjust the pH to 6.5. Subsequently, this aqueous solution was spray-dried with a spray dryer.
以下の工程により、白色微粉末の低分子ヒアルロン酸ナトリウム5.1kg(収率約85%)を得た。このヒアルロン酸は、極限粘度より換算した平均分子量が3.5万であり、分子量分布において、分子量1万以下の成分の割合が40%未満でかつ分子量5万以上の成分の割合が1%超であった。 By the following steps, 5.1 kg (yield of about 85%) of low molecular weight sodium hyaluronate as a white fine powder was obtained. This hyaluronic acid has an average molecular weight converted to intrinsic viscosity of 35,000, and in the molecular weight distribution, the proportion of components having a molecular weight of 10,000 or less is less than 40% and the proportion of components having a molecular weight of 50,000 or more is more than 1%. Met.
〔実施例1〕
下記の配合の発酵乳を製した。つまり、調製例1で得られた平均分子量が9千のヒアルロン酸を清水に溶解し、牛乳、脱脂粉乳と合わせて混合した。次に90℃、10分間の加熱殺菌処理を施した後、40℃まで冷却してヨーグルトスターターを添加し、均一に攪拌して、100mL容個食容器に80mLずつ分注した。これを40℃にて発酵させ、乳酸酸度が0.7%前後に達した時点で10℃以下に冷却し、発酵停止させ発酵乳を製した。
[Example 1]
Fermented milk having the following composition was produced. That is, hyaluronic acid having an average molecular weight of 9,000 obtained in Preparation Example 1 was dissolved in fresh water and mixed with milk and skim milk powder. Next, after heat sterilization treatment at 90 ° C. for 10 minutes, the mixture was cooled to 40 ° C., a yogurt starter was added, and the mixture was stirred uniformly, and dispensed in 80 mL portions into 100 mL individual food containers. This was fermented at 40 ° C., and when the lactic acid acidity reached around 0.7%, it was cooled to 10 ° C. or less, and the fermentation was stopped to produce fermented milk.
<配合割合>
牛乳 80%
脱脂粉乳 3%
ヨーグルトスターター(市販ヨーグルト)3%
ヒアルロン酸(調製例1) 0.0125%/0.075%/0.15%
清水 残余
―――――――――――――――――――――――――――――――――――――――
100%
<Combination ratio>
80% milk
Nonfat dry milk 3%
Yogurt starter (commercial yogurt) 3%
Hyaluronic acid (Preparation Example 1) 0.0125% / 0.075% / 0.15%
Shimizu Residual -――――――――――――――――――――――――――――――――――――――
100%
〔実施例2〕
実施例1の発酵乳で使用したヒアルロン酸の代わりに、調製例2で得られた平均分子量が3.5万のヒアルロン酸ナトリウムを使用する以外は、実施例1と同様に発酵乳を製した。
[Example 2]
Fermented milk was produced in the same manner as in Example 1 except that sodium hyaluronate having an average molecular weight of 35,000 obtained in Preparation Example 2 was used in place of the hyaluronic acid used in the fermented milk of Example 1. .
〔実施例3〕
実施例1の発酵乳で使用したヒアルロン酸の代わりに、平均分子量30万のヒアルロン酸(商品名「ヒアルロンサンHA−LF」、キユーピー(株)製)を使用する以外は、実施例1と同様に発酵乳を製した。
Example 3
Instead of the hyaluronic acid used in the fermented milk of Example 1, a hyaluronic acid having an average molecular weight of 300,000 (trade name “Hyaluronic Sun HA-LF”, manufactured by QP Corporation) was used in the same manner as in Example 1. Fermented milk was made.
〔比較例1〕
実施例1の発酵乳で使用したヒアルロン酸の代わりに、平均分子量80万のヒアルロン酸ナトリウムを使用する以外は、実施例1と同様に発酵乳を製した。
[Comparative Example 1]
Fermented milk was produced in the same manner as in Example 1 except that sodium hyaluronate having an average molecular weight of 800,000 was used instead of hyaluronic acid used in the fermented milk of Example 1.
〔比較例2〕
実施例1の発酵乳で使用したヒアルロン酸の代わりに、平均分子量130万のヒアルロン酸(商品名「ヒアルロンサンHA−LQ」、キユーピー(株)製)を使用する以外は、実施例1と同様に発酵乳を製した。
[Comparative Example 2]
Instead of the hyaluronic acid used in the fermented milk of Example 1, an hyaluronic acid having an average molecular weight of 1.3 million (trade name “Hyaluron San HA-LQ”, manufactured by QP Corporation) was used in the same manner as in Example 1. Fermented milk was made.
〔試験例1〕
実施例1〜3、ならびに比較例1〜2で得られた発酵乳を容器から取り出し、内容物の状態を、下記に示す対照品を基準に目視で評価した。評価結果を表2に示す。
[Test Example 1]
The fermented milk obtained in Examples 1 to 3 and Comparative Examples 1 to 2 was taken out of the container, and the state of the contents was visually evaluated based on the control product shown below. The evaluation results are shown in Table 2.
〔対照品〕
実施例1の発酵乳において、調製例1のヒアルロン酸を添加しなかった以外は同様の方法で発酵乳を製した。
[Control product]
In the fermented milk of Example 1, fermented milk was produced in the same manner except that the hyaluronic acid of Preparation Example 1 was not added.
表2より、本発明の平均分子量30万以下のヒアルロン酸および/またはその塩を配合した実施例1〜3の発酵乳は、平均分子量が30万超のヒアルロン酸および/またはその塩を配合した比較例1又は2で確認された乳の分離がなく、良好な性状であった。また、平均分子量5万以下のヒアルロン酸および/またはその塩を配合した実施例1又は2の発酵乳は、対照品と比較しても、外観の性状はほぼ同等であった。特に、平均分子量が2万以下であり、その分子量分布において、分子量1万以下の成分の割合が40%以上、かつ分子量5万以上の成分の割合が5%以下であるヒアルロン酸を配合した実施例1の発酵乳は、ヒアルロン酸の配合量が多い場合にも性状は対照品と同等であった。 From Table 2, the fermented milk of Examples 1 to 3 blended with hyaluronic acid and / or a salt thereof having an average molecular weight of 300,000 or less according to the present invention blended hyaluronic acid and / or a salt thereof with an average molecular weight exceeding 300,000. There was no separation of milk confirmed in Comparative Example 1 or 2, and the properties were good. In addition, the fermented milk of Example 1 or 2 blended with hyaluronic acid having an average molecular weight of 50,000 or less and / or a salt thereof had almost the same appearance as the control product. In particular, blending with hyaluronic acid having an average molecular weight of 20,000 or less, a molecular weight distribution in which the proportion of components with a molecular weight of 10,000 or less is 40% or more, and the proportion of components with a molecular weight of 50,000 or more is 5% or less The fermented milk of Example 1 had the same properties as the control product even when the amount of hyaluronic acid was large.
Claims (1)
Fermented milk, characterized by containing an average molecular weight 35,000 or less of hyaluronic acid and / or a salt thereof from 0.0125 to 0.15%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007139980A JP4764380B2 (en) | 2007-02-13 | 2007-05-28 | Fermented milk |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007032117 | 2007-02-13 | ||
JP2007032117 | 2007-02-13 | ||
JP2007139980A JP4764380B2 (en) | 2007-02-13 | 2007-05-28 | Fermented milk |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008220359A JP2008220359A (en) | 2008-09-25 |
JP4764380B2 true JP4764380B2 (en) | 2011-08-31 |
Family
ID=39839690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007139980A Expired - Fee Related JP4764380B2 (en) | 2007-02-13 | 2007-05-28 | Fermented milk |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4764380B2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6165449B2 (en) * | 2012-02-01 | 2017-07-19 | 三栄源エフ・エフ・アイ株式会社 | Fermented milk food |
CN116268089B (en) * | 2021-12-02 | 2024-10-29 | 华熙生物科技股份有限公司 | Flavored fermented milk containing hyaluronic acid and preparation method thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1056983A (en) * | 1996-08-13 | 1998-03-03 | Kyodo Nyugyo Kk | How to improve gelled foods |
JP2000102362A (en) * | 1998-09-30 | 2000-04-11 | Seikagaku Kogyo Co Ltd | Food additive and food composition containing the same |
JP2002360292A (en) * | 2001-06-11 | 2002-12-17 | Medicaraise Corp | Method for extracting low molecular weight hyaluronic acid and food containing the low molecular weight hyaluronic acid |
JP2006265287A (en) * | 2005-03-22 | 2006-10-05 | Q P Corp | Low molecular weight hyaluronic acid and/or its salt, its manufacturing process and cosmetic and food composition containing it |
JP2006522591A (en) * | 2003-04-11 | 2006-10-05 | ノボザイムス アクティーゼルスカブ | Dairy products comprising hyaluronic acid |
JP2007514421A (en) * | 2003-12-17 | 2007-06-07 | ノボザイムス バイオポリマー アクティーゼルスカブ | Dairy products comprising a texturizer |
-
2007
- 2007-05-28 JP JP2007139980A patent/JP4764380B2/en not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1056983A (en) * | 1996-08-13 | 1998-03-03 | Kyodo Nyugyo Kk | How to improve gelled foods |
JP2000102362A (en) * | 1998-09-30 | 2000-04-11 | Seikagaku Kogyo Co Ltd | Food additive and food composition containing the same |
JP2002360292A (en) * | 2001-06-11 | 2002-12-17 | Medicaraise Corp | Method for extracting low molecular weight hyaluronic acid and food containing the low molecular weight hyaluronic acid |
JP2006522591A (en) * | 2003-04-11 | 2006-10-05 | ノボザイムス アクティーゼルスカブ | Dairy products comprising hyaluronic acid |
JP2007514421A (en) * | 2003-12-17 | 2007-06-07 | ノボザイムス バイオポリマー アクティーゼルスカブ | Dairy products comprising a texturizer |
JP2006265287A (en) * | 2005-03-22 | 2006-10-05 | Q P Corp | Low molecular weight hyaluronic acid and/or its salt, its manufacturing process and cosmetic and food composition containing it |
Also Published As
Publication number | Publication date |
---|---|
JP2008220359A (en) | 2008-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8933054B2 (en) | Low molecular weight hyaluronic acid and/or salt thereof, method for producing same, and cosmetic preparation and food composition containing same | |
US8367818B2 (en) | Low molecular weight hyaluronic acid and/or salt thereof, and cosmetic preparation, pharmaceutical composition, and food composition each using same | |
US11802168B2 (en) | Polydextrose material | |
JP5496654B2 (en) | Very long chain inulin | |
BRPI0720297B1 (en) | VERY HIGH PERFORMANCE CLARIFIED GELANA GUMMIES | |
CA2649655A1 (en) | Inulin of very high chain length | |
JP2009051877A (en) | New hyaluronic acid and/or salt thereof, food composition and oral medicinal composition using the same, and oral skin ameliorating agent or oral skin water content-increasing agent comprising the hyaluronic acid and/or the salt thereof as active ingredient | |
JP4712746B2 (en) | Acidic beverage | |
Li et al. | Rheological properties of chia seed gum extracted by high-speed shearing and its comparison with commercial polysaccharides | |
JP5130264B2 (en) | Method for producing hyaluronic acid and / or salt thereof | |
JP4764380B2 (en) | Fermented milk | |
JP5479754B2 (en) | Powdered composition and tablet, and method for preventing browning of γ-aminobutyric acid and browning inhibitor | |
JP5723919B2 (en) | Method for producing novel hyaluronic acid and / or salt thereof, and food composition, oral skin improving agent or oral skin water content increasing agent containing hyaluronic acid and / or salt thereof | |
JP2008154571A (en) | Chocolates | |
JP5839924B2 (en) | Acid gel food | |
JP2008173108A (en) | Confectionery | |
BRPI0710867B1 (en) | VERY HIGH CHAIN LENGTH INULIN, ITS USES AND THEIR OBTAINING PROCESS, FOOD GENDER, FOOD SUPPLEMENT, COSMETIC PREPARATION, AND WATER PASTE AND ITS USE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090819 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110223 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110301 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110324 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110412 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110513 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110607 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110610 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140617 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4764380 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |